Travere Therapeutics, Inc.

Mirae Asset Global Investments Co., Ltd. TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/26/2026

Shares

4,348

Value ($000)

166

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/26/2026	166	0.0%	4,348	12/31/2025
2025 Q3	11/3/2025	82	0.0%	3,446	9/30/2025
2025 Q2	7/21/2025	51	0.0%	3,431	6/30/2025
2025 Q1	4/24/2025	58	0.0%	2,969	3/31/2025
2024 Q4	1/27/2025	49	0.0%	2,861	12/31/2024
2024 Q3	10/23/2024	39	0.0%	2,767	9/30/2024
2024 Q2	7/30/2024	19	0.0%	2,273	6/30/2024
2024 Q1	5/1/2024	804	0.0%	50,178	3/31/2024
2023 Q4	1/24/2024	417	0.0%	46,424	12/31/2023
2023 Q3	10/26/2023	387	0.0%	43,341	9/30/2023
2023 Q2	8/10/2023	747	0.0%	48,667	6/30/2023
2023 Q1	5/4/2023	987	0.0%	43,900	3/31/2023
2022 Q4	2/9/2023	664	0.0%	31,560	12/31/2022
2022 Q3	11/10/2022	777	0.0%	31,532	9/30/2022
2022 Q2	8/15/2022	466	0.0%	19,242	6/30/2022